HBV1 O‐14: Bispecific antibody constructs mediate specific retargeting towards and elimination of HBVpositive hepatocytes and tumor cells

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|S2|8-8

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.S2, 2015-06, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical pharmacology of bispecific antibody constructs

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. S3, 2015-03 ,pp. : S21-S28

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combined Inhibition of Tumor Necrosis Factor α and Interleukin‐17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 1, 2015-01 ,pp. : 51-62

John Wiley & Sons Inc

Access to resources Recommend Favorite

Towards HBV curative therapies

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. S1, 2018-02 ,pp. : 102-114

John Wiley & Sons Inc

Access to resources Recommend Favorite

Orexin A protects cells from apoptosis by regulating FoxO1 and mTORC1 through the OX1R/PI3K/AKT signaling pathway in hepatocytes

By        

International Journal of Molecular Medicine, Vol. 34, Iss. 1, 2014-01 ,pp. : 153-159

Spandidos Publications

Access to resources Recommend Favorite

Towards the elimination of onchocerciasis

By Thylefors B.   Alleman M.  

Annals of Tropical Medicine and Parasitology, Vol. 100, Iss. 8, 2006-12 ,pp. : 733-746

Maney Publishing

Access to resources Recommend Favorite